Obesity
Information for healthcare professionals on obesity including guidelines, protocols and evidence on the use of VLCDs.
Highlights of the month
- Clinical Resources
Supporting weight management following GLP-1 de-prescription
One challenge that arises after the completion of any weight loss therapy is weight regain. OPTIFAST VLCD products can be beneficial to help individuals maintain nutritional balance and reduce overall caloric intake to support continued weight management.
